Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the impact of a discontinuous administration of
oxytocin during the active phase of the 1st stage of labor on the neonatal morbidity rate.
The investigators hypothesize that discontinuation of oxytocin in the active phase of labor
(from 6 cm) in women who received oxytocin in the latent phase or for an induction (before 4
cm of dilation) could reduce neonatal morbidity.
Phase:
Phase 4
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborator:
Institut National de la Santé Et de la Recherche Médicale, France